Evidence map›Paper›PMID 21084670›Full record

ReviewJournal of immunology (Baltimore, Md. : 1950)2010

The role of the transcription factor CREB in immune function.

Andy Y Wen, Kathleen M Sakamoto, Lloyd S Miller

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 468 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
468citing papers in PubMed, 2 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

468 citing papers in PubMed, 2 syntheses or guidelines pooled it, 860 citations in OpenAlex.

  1. Pooled it
  2. The Effects of Cannabinoids on Ischemic Stroke-Associated Neuroinflammation: A Systematic Review.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

408 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Andy Y WenDivision of Pediatric Critical Care, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
Kathleen M Sakamoto
Lloyd S Miller
Los Angeles Medical Center · USPediatrics and Genetics · USUniversity of California, Los Angeles · US

Funding

The Role of CREB in Normal Myelopoiesis and LeukemogenesisR01HL075826 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SAKAMOTO, KATHLEEN M · 2004 to 2013
$3.2M
HUMAN AND MOLECULAR DEVELOPMENT TRAINING PROGRAMT32HD007512 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DEVASKAR, SHERIN U · 1998 to 2012
$2.6M
Molecular Pathogenesis of Diamond Blackfan AnemiaR01HL097561 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LIN, SHUO, SAKAMOTO, KATHLEEN M · 2010 to 2013
$1.7M
Innate Immune Response to Staphylococcus aureus in SkinR01AI078910 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MILLER, LLOYD S · 2009 to 2013
$1.7M
Molecular and Cellular Characterization of Myeloproliferative DiseaseR01HL083077 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SAKAMOTO, KATHLEEN M · 2005 to 2010
$1.5M
Host defense against Staphylococcus aureus skin infectionsR03AR054534 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MILLER, LLOYD S · 2008 to 2010
$230k
Novel lipid -based therapies for cystic fibrosisR41HL078526 · NHLBI · AVRION MOLECULAR, INC. · PI KARP, CHRISTOPHER L · 2004 to 2004
$100k
NHLBI NIH HHS HL097561NHLBI NIH HHS HL78526NHLBI NIH HHS R01 HL075826NHLBI NIH HHS R01 HL083077NHLBI NIH HHS R01 HL097561NHLBI NIH HHS R01 HL83077NHLBI NIH HHS R41 HL078526NIAID NIH HHS R01 AI078910NIAMS NIH HHS R03 AR054534NICHD NIH HHS T32 HD007512NICHD NIH HHS T32 HD07512
6 · The paper itself

Abstract

CREB is a transcription factor that regulates diverse cellular responses, including proliferation, survival, and differentiation. CREB is induced by a variety of growth factors and inflammatory signals and subsequently mediates the transcription of genes containing a cAMP-responsive element. Several immune-related genes possess this cAMP-responsive element, including IL-2, IL-6, IL-10, and TNF-α. In addition, phosphorylated CREB has been proposed to directly inhibit NF-κB activation by blocking the binding of CREB binding protein to the NF-κB complex, thereby limiting proinflammatory responses. CREB also induces an antiapoptotic survival signal in monocytes and macrophages. In T and B cells, CREB activation promotes proliferation and survival and differentially regulates Th1, Th2, and Th17 responses. Finally, CREB activation is required for the generation and maintenance of regulatory T cells. This review summarizes current advances involving CREB in immune function--a role that is continually being defined.

Indexed as

AnimalsCell DifferentiationCell ProliferationCell SurvivalCyclic AMP Response Element-Binding ProteinHumansImmunity, CellularCREB1 protein, humanCreb1 protein, mouseCyclic AMP Response Element-Binding Protein

Identifiers

PMID21084670
PMCPMC5519339
OpenAlexW1577872659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.